BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 20089204)

  • 41. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
    Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
    N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated homocysteine levels with weight loss after Lap-Band surgery: higher folate and vitamin B12 levels required to maintain homocysteine level.
    Dixon JB; Dixon ME; O'Brien PE
    Int J Obes Relat Metab Disord; 2001 Feb; 25(2):219-27. PubMed ID: 11410823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms.
    Fillon-Emery N; Chango A; Mircher C; Barbé F; Bléhaut H; Herbeth B; Rosenblatt DS; Réthoré MO; Lambert D; Nicolas JP
    Am J Clin Nutr; 2004 Dec; 80(6):1551-7. PubMed ID: 15585767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people.
    Kwok T; Lee J; Law CB; Pan PC; Yung CY; Choi KC; Lam LC
    Clin Nutr; 2011 Jun; 30(3):297-302. PubMed ID: 21216507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
    Jonasson T; Ohlin AK; Gottsäter A; Hultberg B; Ohlin H
    Clin Chem Lab Med; 2005; 43(6):628-34. PubMed ID: 16006259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
    J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
    Ho GY; Eikelboom JW; Hankey GJ; Wong CR; Tan SL; Chan JB; Chen CP
    Stroke; 2006 Feb; 37(2):456-60. PubMed ID: 16397167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
    Saposnik G; Ray JG; Sheridan P; McQueen M; Lonn E;
    Stroke; 2009 Apr; 40(4):1365-72. PubMed ID: 19228852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation.
    Hirsch S; Pia De la Maza M; Yañez P; Glasinovic A; Petermann M; Barrera G; Gattas V; Escobar E; Bunout D
    Clin Cardiol; 2002 Nov; 25(11):495-501. PubMed ID: 12430779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of smoking on serum concentrations of total homocysteine, folate, vitamin B12, and nitric oxide in pregnancy: a preliminary study.
    Ozerol E; Ozerol I; Gökdeniz R; Temel I; Akyol O
    Fetal Diagn Ther; 2004; 19(2):145-8. PubMed ID: 14764959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials.
    Clarke R
    Indian Heart J; 2000; 52(7 Suppl):S59-64. PubMed ID: 11339443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis.
    Siri PW; Verhoef P; Kok FJ
    J Am Coll Nutr; 1998 Oct; 17(5):435-41. PubMed ID: 9791839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
    de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine.
    Liu C; Wang Q; Guo H; Xia M; Yuan Q; Hu Y; Zhu H; Hou M; Ma J; Tang Z; Ling W
    J Nutr; 2008 Feb; 138(2):311-5. PubMed ID: 18203897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease.
    Loehrer FM; Tschöpl M; Angst CP; Litynski P; Jäger K; Fowler B; Haefeli WE
    Atherosclerosis; 2001 Jan; 154(1):147-54. PubMed ID: 11137094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention.
    Bleie Ø; Refsum H; Ueland PM; Vollset SE; Guttormsen AB; Nexo E; Schneede J; Nordrehaug JE; Nygård O
    Am J Clin Nutr; 2004 Sep; 80(3):641-8. PubMed ID: 15321804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The basis of differential responses to folic acid supplementation.
    Cotlarciuc I; Andrew T; Dew T; Clement G; Gill R; Surdulescu G; Sherwood R; Ahmadi KR
    J Nutrigenet Nutrigenomics; 2011; 4(2):99-109. PubMed ID: 21625172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
    Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.